Jason Coogan, Simplex Trading, joins 'Squawk on the Street' to discuss the relationship between oil and stocks, how traders process this balance and much more.

Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced multiple presentations at the 2026 American ...

Lucra offers corporate loyalty programs reimagined as interactive eSports. But winning ARK as a lead wasn't easy.

A 13-year-old boy with no history presented after 4 days of progressively worsening whole body rash.Nine days before ...

The Chairperson of Parliament's Public Accounts Committee (PAC), Steven Baba Malondera Kamsiyamo, MP, has lodged a formal complaint accusing the Acting Director General of the Anti-Corruption Bureau ...

Replimune received a second FDA complete response letter for RP1 in advanced melanoma, raising questions about the viability of its oncolytic immunotherapy program. Replimune Group received a complete ...

What started as a late-40s idea that most biotech experts would have called impossible is now a $7.9 billion company. Built ...

In a collective exhibition titled 'Shared Matter', Swiss designers are presenting global collaborations at this year's Milan ...

Malawi’s anti-corruption chief is accused of using confidential case files to pressure a parliamentary probe into a ...

The Tribunal held that differential CVD cannot be demanded without evidence linking the importer to MRP alteration. Allegations based on assumptions and third-party actions were ...

Detailed price information for Annovis Bio Inc (ANVS-N) from The Globe and Mail including charting and trades.